GlaxoSmithKline (Spain)

589 papers and 14.2k indexed citations i.

About

In recent decades, authors affiliated with GlaxoSmithKline (Spain) have published 589 papers, which have received a total of 14.2k indexed citations. Scholars at this organization have produced 162 papers in Epidemiology, 140 papers in Molecular Biology and 134 papers in Infectious Diseases on the topics of Malaria Research and Control (82 papers), Tuberculosis Research and Epidemiology (62 papers) and Asthma and respiratory diseases (50 papers). Their work is cited by papers focused on Epidemiology (3.8k citations), Molecular Biology (3.4k citations) and Public Health, Environmental and Occupational Health (3.0k citations). Authors at GlaxoSmithKline (Spain) collaborate with scholars in Spain, United States and United Kingdom and have published in prestigious journals including Nature, Science and Proceedings of the National Academy of Sciences. Some of GlaxoSmithKline (Spain)'s most productive authors include César Garcı́a-Rey, Francisco‐Javier Gamo, Lluís Ballell, Marc Miravitlles, Julio Ancochea, Francisco García‐Río, José Garcia-Bustos, Joan B. Soriano, Esperanza Herreros and Enric Duran‐Tauleria.

In The Last Decade

Fields of papers published by authors at GlaxoSmithKline (Spain)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with GlaxoSmithKline (Spain) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with GlaxoSmithKline (Spain) at the time of their publication.

Countries citing scholars working at GlaxoSmithKline (Spain)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at GlaxoSmithKline (Spain). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at GlaxoSmithKline (Spain) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GlaxoSmithKline (Spain) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025